About
Advanced diabetes technologies like insulin pumps and continuous glucose monitoring devices are the most effective tools to help people manage life with type 1 diabetes. These technologies prevent life-limiting and expensive complications and should be readily accessible to all who are willing and able to use them appropriately. However, both financial and non-financial barriers make individuals with social disadvantage (e.g., low income, visible minority, language barrier) less likely to initiate diabetes technologies, contributing to worse diabetes outcomes.
We are currently conducting a three-phase research project (EQUAT1D) that will develop strategies for increasing the initiation of diabetes technologies among adults with type 1 diabetes who are socially disadvantaged via specific tools for patients and their providers. This research will build on the EQUAT1D study, progressing it to a pivotal next stage: developing the specific clinical tools used in the program, then evaluating its feasibility and potential clinical effectiveness with a randomized controlled trial. This research will inform a larger definitive trial and influence health policy and clinical practice for type 1 diabetes in Ontario, leading to more equitable outcomes and saving healthcare costs.
Proposed Project
Building on our ongoing EQUAT1D study, which will finalize a patient- and provider-level behaviour change strategy to increase technology uptake among socially disadvantaged individuals living with T1D, this project focuses on the key next translational steps:
Accepting Students
An MSc or PHD student will be recruited to finalize the trial protocol, oversee patient recruitment, deliver the intervention, and perform data collection and analysis.
Lead Faculty
Affiliated Faculty
